Cadila Healthcare
Jenis perusahaan | Publik |
|---|---|
| Kode emiten | |
| Industri | Farmasi |
| Didirikan | 1952 |
| Pendiri | Ramanbhai Patel |
| Kantor pusat | Ahmedabad, Gujarat, India |
Tokoh kunci | Pankaj R. Patel, Ketua, Sharvil P. Patel, Direktur Manajer |
| Pendapatan | |
| ₹1.602,10 crore (US$220 juta) [1] (2019) | |
Karyawan | 29.000 (2020) |
| Situs web | www |
Cadila Healthcare Limited (juga dikenal sebagai Zydus Cadila) adalah sebuah perusahaan farmasi India yang bermarkas besar di Ahmedabad, Gujarat, India,[2] dengan pendapatan ₹7,104.30 crore (US$1.0 miliar) pada 2019.[1] Perusahaan tersebut adalah produsen obat generik.[3]
Referensi
- ^ a b c "Cadila Healthcare Profit and Loss Reports - The Economic Times". economictimes.indiatimes.com. Diakses tanggal 2020-06-15.
- ^ "A Complete Overview on Cadila Healthcare, a growing and popular company in India". business.mapsofindia.com. 21 June 2011. Diakses tanggal 2009-02-04.
- ^ "Zydus launches SoviHep - the breakthrough therapy for Hepatitis C in alliance with Gilead Sciences". The Hindu Business Line (dalam bahasa Inggris). 2015-03-17. Diakses tanggal 2017-12-29.
Pranala luar
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.